To the Editor: Tests for serum vitamin B12 and red cell folate levels are commonly requested in elderly inpatients1 to rule out reversible causes of cognitive impairment (eg, delirium).2 This imposes some cost on the community. The evidence for the association of cognitive impairment and vitamin B12 deficiency is inconclusive.3,4 It is also unclear whether other markers, such as elevated mean corpuscular volume (MCV) and anaemia, can indicate the need for vitamin B12 testing in elderly inpatients without known risk factors for vitamin B12 deficiency (such as coeliac disease and pernicious anaemia).
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Medicare Australia. Medicare item reports. https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml (accessed Feb 2011).
- 2. Pond D, Brodaty H. Diagnosis and management of dementia in general practice. Aust Fam Physician 2004; 33: 789-793.
- 3. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 2008; 29 (2 Suppl): S143-S172.
- 4. Raman G, Tatsioni A, Chung M, et al. Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr 2007; 137: 1789-1794.
No relevant disclosures.